United Therapeutics | 8-K: Current report
United Therapeutics | 8-K: United Therapeutics Corporation Reports First Quarter 2024 Financial Results
United Therapeutics | DEFA14A: Others
United Therapeutics | DEF 14A: Definitive information statements
United Therapeutics | 8-K: Current report
United Therapeutics | 8-K: Current report
United Therapeutics | 8-K: United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
United Therapeutics | 8-K: Current report
United Therapeutics | 8-K: Current report
United Therapeutics | 8-K: United Therapeutics Corporation Reports Third Quarter 2023 Financial Results
United Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
United Therapeutics | 8-K: United Therapeutics Corporation Reports Second Quarter 2023 Financial Results
United Therapeutics | 8-K: Current report
United Therapeutics | 8-K/A: Current report (Amendment)
United Therapeutics | 8-K: Current report
United Therapeutics | 8-K: UNITED THERAPEUTICS CORPORATION REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
United Therapeutics | DEFA14A: Others
United Therapeutics | DEF 14A: Definitive proxy statements
United Therapeutics | 8-K: Current report
United Therapeutics | 8-K: Current report
No Data